{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:41:56Z","timestamp":1791333716522,"version":"4.3.1"},"reference-count":60,"publisher":"Microbiology Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9,1]]},"abstract":"<jats:p>Although the 2003 severe acute respiratory syndrome (SARS) outbreak was controlled, repeated transmission of SARS coronavirus (CoV) over several years makes the development of a SARS vaccine desirable. We performed a comparative evaluation of two SARS vaccines for their ability to protect against live SARS-CoV intranasal challenge in ferrets. Both the whole killed SARS-CoV vaccine (with and without alum) and adenovirus-based vectors encoding the nucleocapsid (N) and spike (S) protein induced neutralizing antibody responses and reduced viral replication and shedding in the upper respiratory tract and progression of virus to the lower respiratory tract. The vaccines also diminished haemorrhage in the thymus and reduced the severity and extent of pneumonia and damage to lung epithelium. However, despite high neutralizing antibody titres, protection was incomplete for all vaccine preparations and administration routes. Our data suggest that a combination of vaccine strategies may be required for effective protection from this pathogen. The ferret may be a good model for SARS-CoV infection because it is the only model that replicates the fever seen in human patients, as well as replicating other SARS disease features including infection by the respiratory route, clinical signs, viral replication in upper and lower respiratory tract and lung damage.<\/jats:p>","DOI":"10.1099\/vir.0.2008\/001891-0","type":"journal-article","created":{"date-parts":[[2008,8,27]],"date-time":"2008-08-27T15:45:58Z","timestamp":1219851958000},"page":"2136-2146","source":"Crossref","is-referenced-by-count":77,"title":["Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines"],"prefix":"10.1099","volume":"89","author":[{"given":"Raymond H.","family":"See","sequence":"first","affiliation":[{"name":"University of British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Petric","sequence":"additional","affiliation":[{"name":"University of British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Lawrence","sequence":"additional","affiliation":[{"name":"University of British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine P. Y.","family":"Mok","sequence":"additional","affiliation":[{"name":"University of British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rowe","sequence":"additional","affiliation":[{"name":"Southern Research Institute, Birmingham, AL 35205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois A.","family":"Zitzow","sequence":"additional","affiliation":[{"name":"Southern Research Institute, Birmingham, AL 35205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuna P.","family":"Karunakaran","sequence":"additional","affiliation":[{"name":"University of British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Voss","sequence":"additional","affiliation":[{"name":"Southern Research Institute, Birmingham, AL 35205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Brunham","sequence":"additional","affiliation":[{"name":"University of British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Gauldie","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Molecular Medicine and Biology, McMaster University, Hamilton, ON L8N 3Z5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Brett","family":"Finlay","sequence":"additional","affiliation":[{"name":"Michael Smith Laboratories and Departments of Biochemistry and Molecular Biology and Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Roper","sequence":"additional","affiliation":[{"name":"Brody School of Medicine, Department of Microbiology and Immunology, East Carolina University, Greenville, NC 27834, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-1702(96)01390-1","article-title":"Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies","volume":"46","author":"Anton","year":"1996","journal-title":"Virus Res"},{"key":"R2","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice","volume":"101","author":"Bisht","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R3","first-page":"8","article-title":"Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus","volume":"74","author":"Boots","year":"1991","journal-title":"Immunology"},{"key":"R4","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(04)16501-X","article-title":"Mucosal immunisation of African green monkeys ( Cercopithecus aethiops ) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS","volume":"363","author":"Bukreyev","year":"2004","journal-title":"Lancet"},{"key":"R5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/03079450310001621198","article-title":"Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus","volume":"32","author":"Cavanagh","year":"2003","journal-title":"Avian Pathol"},{"key":"R6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3201\/eid1002.030610","article-title":"Detection of SARS coronavirus in patients with suspected SARS","volume":"10","author":"Chan","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"R7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1086\/504943","article-title":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003\u20132004 community outbreak of SARS in Guangzhou, China","volume":"43","author":"Che","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3201\/eid1103.040824","article-title":"SARS-associated coronavirus transmitted from human to pig","volume":"11","author":"Chen","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"R9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virol.2007.12.032","article-title":"The SARS-CoV ferret model in an infection-challenge study","volume":"374","author":"Chu","year":"2008","journal-title":"Virology"},{"key":"R10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0145-305X(99)00072-5","article-title":"Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry","volume":"24","author":"Collisson","year":"2000","journal-title":"Dev Comp Immunol"},{"key":"R11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1086\/378587","article-title":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome","volume":"37","author":"Cui","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R12","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.vaccine.2005.01.033","article-title":"Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets","volume":"23","author":"Czub","year":"2005","journal-title":"Vaccine"},{"key":"R13","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/522431","article-title":"Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets","volume":"196","author":"Darnell","year":"2007","journal-title":"J Infect Dis"},{"key":"R14","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1371\/journal.pmed.0030525","article-title":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants","volume":"3","author":"Deming","year":"2006","journal-title":"PLoS Med"},{"key":"R15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/path.1560","article-title":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways","volume":"203","author":"Ding","year":"2004","journal-title":"J Pathol"},{"key":"R16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-4615-1899-0_34","article-title":"Development of protection against coronavirus induced diseases","volume":"380","author":"Enjuanes","year":"1995","journal-title":"A review. Adv Exp Med Biol"},{"key":"R17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nrmicro930","article-title":"Rapid response research to emerging infectious diseases: lessons from SARS","volume":"2","author":"Finlay","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"R18","first-page":"152","article-title":"SARS virus returns to China as scientists race to find effective vaccine","volume":"82","author":"Fleck","year":"2004","journal-title":"Bull World Health Organ"},{"key":"R19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/423240a","article-title":"Aetiology: Koch's postulates fulfilled for SARS virus","volume":"423","author":"Fouchier","year":"2003","journal-title":"Nature"},{"key":"R20","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.4049\/jimmunol.173.6.4030","article-title":"Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice","volume":"173","author":"Glass","year":"2004","journal-title":"J Immunol"},{"key":"R21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.1087139","article-title":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China","volume":"302","author":"Guan","year":"2003","journal-title":"Science"},{"key":"R22","first-page":"332","article-title":"Study of laboratory characteristic of 4 patients with sporadic severe acute respiratory syndrome in 2004","volume":"17","author":"Guan","year":"2005","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"R23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.virol.2004.04.017","article-title":"SARS corona virus peptides recognized by antibodies in the sera of convalescent cases","volume":"324","author":"Guo","year":"2004","journal-title":"Virology"},{"key":"R24","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1128\/JVI.78.20.11416-11421.2004","article-title":"Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires stat1","volume":"78","author":"Hogan","year":"2004","journal-title":"J Virol"},{"key":"R25","volume-title":"Nonparametric Statistical Methods","author":"Hollander","year":"1973"},{"key":"R26","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI18819","article-title":"SARS coronavirus: a new challenge for prevention and therapy","volume":"111","author":"Holmes","year":"2003","journal-title":"J Clin Invest"},{"key":"R27","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1128\/JVI.78.9.4638-4645.2004","article-title":"Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus","volume":"78","author":"Kim","year":"2004","journal-title":"J Virol"},{"key":"R28","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1016\/j.vaccine.2007.04.065","article-title":"Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques","volume":"25","author":"Kobinger","year":"2007","journal-title":"Vaccine"},{"key":"R29","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1073\/pnas.0506735102","article-title":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats","volume":"102","author":"Lau","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1371\/journal.pmed.0030149","article-title":"Cynomolgus macaque as an animal model for severe acute respiratory syndrome","volume":"3","author":"Lawler","year":"2006","journal-title":"PLoS Med"},{"key":"R31","first-page":"981","article-title":"The relationship between serum interleukins and T-lymphocyte subsets in patients with severe acute respiratory syndrome","volume":"116","author":"Li","year":"2003","journal-title":"Chin Med J (Engl"},{"key":"R32","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.1085953","article-title":"The genome sequence of the SARS-associated coronavirus","volume":"300","author":"Marra","year":"2003","journal-title":"Science"},{"key":"R33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/425915a","article-title":"SARS virus infection of cats and ferrets","volume":"425","author":"Martina","year":"2003","journal-title":"Nature"},{"key":"R34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/13550280490280292","article-title":"Coronavirus replication and pathogenesis: implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development","volume":"10","author":"Navas-Martin","year":"2004","journal-title":"J Neurovirol"},{"key":"R35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-1135(93)90126-R","article-title":"A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination","volume":"36","author":"Olsen","year":"1993","journal-title":"Vet Microbiol"},{"key":"R36","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1099\/0022-1317-74-4-745","article-title":"Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity","volume":"74","author":"Olsen","year":"1993","journal-title":"J Gen Virol"},{"key":"R37","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"R38","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1128\/JVI.00505-07","article-title":"Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice","volume":"81","author":"Rockx","year":"2007","journal-title":"J Virol"},{"key":"R39","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1085952","article-title":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome","volume":"300","author":"Rota","year":"2003","journal-title":"Science"},{"key":"R40","first-page":"81","article-title":"Diagnostic procedures for viral, rickettsial and chlamydia infections","volume-title":"Cell Culture Procedures for Diagnostic Virology","author":"Schmidt","year":"1989"},{"key":"R41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/1573395054065106","article-title":"Rapid response research \u2013 SARS coronavirus vaccines and application of processes to other emerging infectious diseases","volume":"1","author":"See","year":"2005","journal-title":"Curr Immunol Rev"},{"key":"R42","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1099\/vir.0.81579-0","article-title":"Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus","volume":"87","author":"See","year":"2006","journal-title":"J Gen Virol"},{"key":"R43","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1128\/JVI.71.10.7889-7894.1997","article-title":"The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection","volume":"71","author":"Seo","year":"1997","journal-title":"J Virol"},{"key":"R44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.med.56.091103.134135","article-title":"Severe acute respiratory syndrome (SARS): a year in review","volume":"56","author":"Skowronski","year":"2005","journal-title":"Annu Rev Med"},{"key":"R45","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1128\/JVI.67.12.7050-7059.1993","article-title":"Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain","volume":"67","author":"Stohlman","year":"1993","journal-title":"J Virol"},{"key":"R46","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/JVI.69.2.684-694.1995","article-title":"Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system","volume":"69","author":"Stohlman","year":"1995","journal-title":"J Virol"},{"key":"R47","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/JVI.78.7.3572-3577.2004","article-title":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice","volume":"78","author":"Subbarao","year":"2004","journal-title":"J Virol"},{"key":"R48","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(04)16506-9","article-title":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets","volume":"363","author":"ter Meulen","year":"2004","journal-title":"Lancet"},{"key":"R49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/path.1510","article-title":"Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in situ hybridization study of fatal cases","volume":"202","author":"To","year":"2004","journal-title":"J Pathol"},{"key":"R50","first-page":"84","article-title":"Surveillance on severe acute respiratory syndrome associated coronavirus in animals at a live animal market of Guangzhou in 2004","volume":"26","author":"Wang","year":"2005","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"R51","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1128\/JVI.78.22.12672-12676.2004","article-title":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets","volume":"78","author":"Weingartl","year":"2004","journal-title":"J Virol"},{"key":"R52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0147-9571(81)90003-5","article-title":"Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever","volume":"4","author":"Weiss","year":"1981","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"R53","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1099\/0022-1317-74-10-2061","article-title":"Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infection","volume":"74","author":"Wesseling","year":"1993","journal-title":"J Gen Virol"},{"key":"R54","article-title":"Annex Table 2. Deaths by cause, sex and mortality stratum in WHO regions, estimates for","year":"2004a"},{"key":"R55","article-title":"Update 4: Review of probable and laboratory-confirmed SARS cases in southern China","volume-title":"Epidemic and Pandemic Alert and Response","year":"2004b"},{"key":"R56","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"key":"R57","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/pmic.200300676","article-title":"Proteomic analysis on structural proteins of Severe Acute Respiratory Syndrome coronavirus","volume":"4","author":"Ying","year":"2004","journal-title":"Proteomics"},{"key":"R58","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1016\/j.vaccine.2005.04.011","article-title":"Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines","volume":"23","author":"Zakhartchouk","year":"2005","journal-title":"Vaccine"},{"key":"R59","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3201\/eid1002.030533","article-title":"SARS-related virus predating SARS outbreak, Hong Kong","volume":"10","author":"Zheng","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"R60","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1128\/JVI.76.9.4420-4429.2002","article-title":"Pathogenesis of avian influenza A (H5N1) viruses in ferrets","volume":"76","author":"Zitzow","year":"2002","journal-title":"J Virol"}],"container-title":["Journal of General Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.2008\/001891-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T13:14:55Z","timestamp":1604495695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.2008\/001891-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,1]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9,1]]}},"URL":"https:\/\/doi.org\/10.1099\/vir.0.2008\/001891-0","relation":{},"ISSN":["0022-1317","1465-2099"],"issn-type":[{"value":"0022-1317","type":"print"},{"value":"1465-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,1]]}}}